China Prioritizes Rare Disease Care in 2026, Vows ‘No One Left Behind’
China strengthens support for rare disease patients in 2026, expanding treatment access and affordability to ensure no community is overlooked.
News & Insights Across Asia
China strengthens support for rare disease patients in 2026, expanding treatment access and affordability to ensure no community is overlooked.
China and the UK unite to tackle rare childhood diseases through a new medical partnership, aiming to improve treatment and research outcomes.
China approves its first gene therapy for hemophilia B, BBM-H901, offering a potential long-term treatment for patients and advancing genomic medicine in Asia.